Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 144.30 INR
Change Today +4.25 / 3.03%
Volume 16.0K
HKCI On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

hikal ltd (HKCI) Snapshot

Open
140.00
Previous Close
140.05
Day High
147.00
Day Low
137.00
52 Week High
01/2/15 - 167.35
52 Week Low
05/16/14 - 85.44
Market Cap
11.9B
Average Volume 10 Days
46.6K
EPS TTM
7.77
Shares Outstanding
82.2M
EX-Date
08/14/14
P/E TM
18.6x
Dividend
0.50
Dividend Yield
0.34%
Current Stock Chart for HIKAL LTD (HKCI)

Related News

No related news articles were found.

hikal ltd (HKCI) Related Businessweek News

No Related Businessweek News Found

hikal ltd (HKCI) Details

Hikal Limited is engaged in the research, development, manufacture, and marketing of fine chemicals for the pharmaceutical and agrochemical industries. It collaborates with companies and offer solutions in contract research, custom synthesis, and custom manufacturing. The company is engaged in the supply of molecules for discovery research on a contract basis; development of non-infringing processes; and method validation of new substances, such as in-process analysis, identification, and quantification of impurities. It also undertakes custom manufacturing of various intermediates and active substances for pharmaceutical and agrochemical companies worldwide; and supplies building blocks for discovery research on a contract basis. The company’s intermediates are used in new candidate drugs in Phase I, Phase II, and Phase III stage of clinical trials, as well as in commercialized drugs. Hikal Limited was founded in 1988 and is headquartered in Navi Mumbai, India.

Founded in 1988

hikal ltd (HKCI) Top Compensated Officers

Chairman, Managing Director and Member of Sha...
Total Annual Compensation: 19.2M
Joint Managing Director, President, Executive...
Total Annual Compensation: 11.1M
Compensation as of Fiscal Year 2014.

hikal ltd (HKCI) Key Developments

Hikal Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Hikal Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales/income from operation of INR 2,250.5 million against INR 2,164.2 million a year ago. Profit from operations before other income and interest was INR 317.4 million against INR 321.0 million a year ago. Profit from ordinary activities before tax was INR 131.0 million against INR 151.7 million a year ago. Net profit after tax was INR 93.7 million against INR 102.8 million a year ago. Basic and diluted earnings per share were INR 5.70 against INR 6.25 a year ago. EBITDA was INR 480 million compared to INR 460 million a year ago. For the nine months, the company reported net sales/income from operation of INR 6,583.3 million against INR 6,016.8 million a year ago. Profit from operations before other income and interest was INR 917.3 million against INR 1,060.4 million a year ago. Profit from ordinary activities before tax was INR 421.2 million against INR 814.3 million a year ago. Net profit after tax was INR 303.3 million against INR 610.2 million a year ago. Basic and diluted earnings per share were INR 18.45 against INR 37.12 a year ago. EBITDA was INR 1,380 million compared to INR 1,470 million a year ago. Adjusted net profit was INR 300 million compared to INR 353.2 million a year ago.

Hikal Limited to Report Q3, 2015 Results on Jan 29, 2015

Hikal Limited announced that they will report Q3, 2015 results on Jan 29, 2015

Hikal Limited, Board Meeting, Jan 29, 2015

Hikal Limited, Board Meeting, Jan 29, 2015. Agenda: To consider and to take on record the unaudited financial results for the quarter ended December 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HKCI:IN 144.30 INR +4.25

HKCI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HKCI.
View Industry Companies
 

Industry Analysis

HKCI

Industry Average

Valuation HKCI Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HIKAL LTD, please visit www.hikal.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.